Baird raised the firm’s price target on Iqvia to $251 from $235 and keeps a Neutral rating on the shares. The firm raised estimates and its price target modestly noting its numbers don’t change dramatically, but confidence improves following TAS outperformance in Q2.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV:
- IQV Earnings this Week: How Will it Perform?
- Iqvia price target lowered to $235 from $241 at Baird
- Iqvia price target lowered to $255 from $275 at Barclays
- ‘The CRO Sector Looks Appealing,’ Says Goldman Sachs — Here Are 2 Stocks to Consider
- Dollar Tree downgraded, Lululemon upgraded: Wall Street’s top analyst calls